Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life

American Journal of Clinical Nutrition

Volumn 94, Issue 6, 2011, Pages

  Newbold, Retha R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTROGEN;

ADIPOCYTE; ADIPOGENESIS; CONFERENCE PAPER; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; GENITAL SYSTEM DISEASE; HUMAN; NONHUMAN; OBESITY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; SPONTANEOUS ABORTION; DEVELOPMENT; DEVELOPMENTAL EXPOSURE; EXPOSURE; FEMALE GENITAL SYSTEM; PUBLIC HEALTH; REVIEW; STRUCTURE ANALYSIS;

ADIPOCYTES; ANIMALS; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EPIDEMIOLOGIC STUDIES; ESTROGENS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; MODELS, ANIMAL; OBESITY; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; PUBLIC HEALTH; REPRODUCTION;

ANIMALIA; MURINAE;

EID: 82355163461     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.001057     Document Type: Conference Paper

References (53)

1. Soto AM, Maffini MV, Sonnenschein C. Neoplasia as development gone awry: the role of endocrine disruptors. Int J Androl 2008;31: 288-93.
2. Colborn T, Dumanoski D, Myers JP. Our stolen future. New York, NY: Penguin Books USA, Inc, 1996.
3. Soto AM, Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol 2010;6:363-70.
4. Needham LL, Calafat AM, Barr DB. Assessing developmental toxicant exposures via biomonitoring. Basic Clin Pharmacol Toxicol 2008;102: 100-8. (Pubitemid 351143433)
5. Bern B. The fragile fetus. Princeton, NJ: Princeton Scientific Publishing Co, 1992.
6. NIH. DES research update. Bethesda, MD: NIH, 1999. (NIH publication no. 00-4722.)
7. Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 2004;199:142-50. (Pubitemid 39094532)
8. Newbold RR, Padilla-Banks E, Jefferson WN. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006;147:S11-7. (Pubitemid 43764585)
9. Brouwers MM, Feitz WF, Roelofs LA, Kiemeney LA, de Gier RP, Roeleveld N. Hypospadias: a transgenerational effect of diethylstilbestrol? Hum Reprod 2006;21:666-9. (Pubitemid 43372971)
10. Titus-Ernstoff L, Troisi R, Hatch EE, et al. Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES). Int J Androl 2010;33:377-84.
11. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31:1235-9. (Pubitemid 36204489)
12. Kaufman D, Banerji MA, Shorman I, et al. Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes 2007;56:1382-6. (Pubitemid 46715631)
13. Levin ED. Fetal nicotinic overload, blunted sympathetic responsivity, and obesity. Birth Defects Res A Clin Mol Teratol 2005;73:481-4. (Pubitemid 41045294)
14. Gluckman PD, Hanson MA, Pinal C. The developmental origins of adult disease. Matern Child Nutr 2005;1:130-41. (Pubitemid 41702541)
15. Gilbert SF. Mechanisms for the environmental regulation of gene expression: ecological aspects of animal development. J Biosci 2005;30: 65-74. (Pubitemid 40571501)
16. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-9.
17. Herbst AL, Bern HA. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York, NY: Thieme-Stratton Inc, 1981.
18. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.
19. Hatch EE, Palmer JR, Titus-Ernstoff L, et al. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 1998;280:630-4. (Pubitemid 28502640)
20. Blatt J, Van Le L, Weiner T, Sailer S. Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol. J Pediatr Hematol Oncol 2003;25:635-6. (Pubitemid 36959425)
21. Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997;57:1338-45. (Pubitemid 27516636)
22. Miller C, Degenhardt K, Sassoon DA. Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis. Nat Genet 1998; 20:228-30. (Pubitemid 28507663)
23. Li S, Hansman R, Newbold R, Davis B, McLachlan JA, Barrett JC. Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 2003;38:78-84. (Pubitemid 37255143)
24. Tang WY, Newbold R, Mardilovich K, et al. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 2008;149: 5922-31.
25. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007;29:1-5. (Pubitemid 47229648)
26. Cunningham E. Where can I find obesity statistics? J Am Diet Assoc 2010;110:656.
27. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
28. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002;8:185-92. (Pubitemid 34438491)
29. Heindel JJ. Endocrine disruptors and the obesity epidemic. Toxicol Sci 2003;76:247-9. (Pubitemid 38035417)
30. Heindel JJ, Levin E. Developmental origins and environmental influences-introduction. NIEHS symposium. Birth Defects Res A Clin Mol Teratol 2005;73:469. (Pubitemid 41045288)
31. Newbold RR, Padilla-Banks E, Jefferson WN. Environmental estrogens and obesity. Mol Cell Endocrinol 2009;304:84-9.
32. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl 2008;31:201-8.
33. Grun F, Watanabe H, Zamanian Z, et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 2006;20:2141-55. (Pubitemid 44286710)
34. vom Saal FS, Akingbemi BT, Belcher SM, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007;24:131-8. (Pubitemid 47385099)
35. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature 1999;401: 763-4. (Pubitemid 129515829)
36. Ashby J, Tinwell H, Haseman J. Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol 1999;30:156-66.
37. Takai Y, Tsutsumi O, Ikezuki Y, et al. Preimplantation exposure to bisphenol A advances postnatal development. Reprod Toxicol 2001;15: 71-4. (Pubitemid 32057605)
38. Honma S, Suzuki A, Buchanan DL, Katsu Y, Watanabe H, Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 2002; 16:117-22. (Pubitemid 34457183)
39. Nikaido Y, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, Tsubura A. Effects of prepubertal exposure to xenoestrogen on development of estrogen target organs in female CD-1 mice. In Vivo 2005;19:487-94. (Pubitemid 40568125)
40. Nikaido Y, Yoshizawa K, Danbara N, et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 2004;18:803-11. (Pubitemid 38987967)
41. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001; 109:675-80. (Pubitemid 32785423)
42. vom Saal FS, Myers JP. Bisphenol A and risk of metabolic disorders. JAMA 2008;300:1353-5.
43. Somm E, Schwitzgebel VM, Toulotte A, et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 2009;117:1549-55.
44. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, Seeley RJ. Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010;151:2603-12.
45. Sakurai K, Kawazuma M, Adachi T, et al. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004;141: 209-14. (Pubitemid 38250890)
46. Masuno H, Kidani T, Sekiya K, et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 2002;43:676-84. (Pubitemid 34477893)
47. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84:319-27. (Pubitemid 40542291)
48. Alonso-Magdalena P, Laribi O, Ropero AB, et al. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 2005; 113:969-77. (Pubitemid 41149624)
49. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006; 114:106-12. (Pubitemid 43056876)
50. Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 2009;304:49-54.
51. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008;116:1642-7.
52. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 2008;31:194-200.
53. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004; 51:165-9. (Pubitemid 38657551)